Evaluation of the clinical effect of Tiaozangyangfei decoction on stable phase of chronic obstructive pulmonary disease with deficiency of both lung and kidney by FRAX and bone metabolic biochemical indexes
- Conditions
- COPD
- Registration Number
- ITMCTR2000003872
- Lead Sponsor
- Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
(1) meet the criteria of TCM Syndrome diagnosis for stable COPD;
(2) aged 40 to 80 years old;
(3) patient denied participating in clinical trial of other drugs within 1 month;
(4) patient volunteered to take the trial and signed informed consent form.
(1) patients with acute exacerbation of chronic obstructive pulmonary disease;
(2) patients with chronic wheezing and chronic cough caused by asthma, lung and bronchial tumors, Tuberculosis, bronchiectasis and allergens;
(3) women in pregnancy and lactation with severe heart and lung diseases;
(4) with primary diseases of the serious circulatory system, urinary system, digestive system, blood system, endocrine and rheumatic immune system, include patients with cancer or AIDS;
(5) the definition of persons with disabilities as set out in the relevant legal articles, including blindness, deafness, muteness, mental retardation, Mental Retardation, etc.;
(6) alcohol and certain drugs are suspected of having been abused in patients; Or other medical history that significantly reduces the likelihood of admission or complicates the whole process of admission, such as frequent changes of place of work or residence, which may result in loss of follow-up;
(7) patients undergoing clinical trials of other drugs in the last month.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pulmonary function;
- Secondary Outcome Measures
Name Time Method